home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

101.66 +0.98 (+0.97%)

Official Closing Price Updated: 7:00 PM EDT, Jul 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

56 57 Next >

3 Magnificent Dividend Stocks to Buy in October ↗

October 06, 2024

These dividend stocks are great picks as the fall season gets underway.

Via The Motley Fool

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades ↗

October 05, 2024

Investors can find market-trouncing blue chip stocks in the healthcare industry.

Via The Motley Fool

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. ↗

October 03, 2024

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Via Investor's Business Daily

Topics Stocks

Down More Than 50%, Is DexCom Stock a Bargain Now? ↗

October 02, 2024

Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market.

Via The Motley Fool

2 Excellent Dividend Stocks to Buy With Less Than $200 ↗

September 28, 2024

Abbott Laboratories and Johnson & Johnson both have raised their dividends annually for more than 50 years.

Via The Motley Fool

Navigating 6 Analyst Ratings For Abbott Laboratories ↗

September 26, 2024

Via Benzinga

Why ABBOTT LABORATORIES (NYSE:ABT) should be investigated by quality investors. ↗

September 11, 2024

Is ABBOTT LABORATORIES (NYSE:ABT) a Strong Candidate for Quality Investing?

Via Chartmill

Looking Into Abbott Laboratories's Recent Short Interest ↗

August 29, 2024

Via Benzinga

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

September 25, 2024

These dividend players could lift your portfolio no matter what the market is doing.

Via The Motley Fool

Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst ↗

September 19, 2024

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation.

Via Benzinga

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

September 19, 2024

Via Benzinga

20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates ↗

September 18, 2024

Investors are anticipating the first cut to the federal funds rate in over four years at the September FOMC meeting. The market is divided on the magnitude of the cut, which could trigger significant...

Via Benzinga

Topics Economy Stocks

Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns

September 17, 2024

These reliable dividend stocks are great buys, with shares still near the bottom of long-term ranges and accelerating growth expected in 2025.

Via MarketBeat

Topics Economy

Can AbbVie Regain Its Status As a Top Dividend Growth Stock? ↗

September 16, 2024

The dividend growth powerhouse is turning the corner.

Via The Motley Fool

Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy? ↗

September 16, 2024

The company continues to flex its innovative muscles.

Via The Motley Fool

3 Stocks to Buy and Hold Forever ↗

September 14, 2024

These stocks are built for the long run.

Via The Motley Fool

3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold ↗

September 13, 2024

These stocks have increased their payouts for decades.

Via The Motley Fool

2 Stocks That Are Passive Income Machines to Buy and Hold Forever ↗

September 11, 2024

You can take these dividends straight to the bank.

Via The Motley Fool

Medtronic Stock: Growth On Rise of the Cardiovascular Machines

September 09, 2024

Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases

Via MarketBeat

Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System ↗

September 05, 2024

Abbott recalls some FreeStyle Libre 3 sensors due to incorrect glucose readings, risking severe health issues.

Via Benzinga

Topics Product Recall

Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device ↗

September 05, 2024

The companies are now duking it out for a new population of CGM users.

Via Investor's Business Daily

3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever ↗

August 30, 2024

These three have secure core businesses, plus multiple paths to grow.

Via The Motley Fool

Patchy But Still Bullish ↗

September 02, 2024

Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.

Via Talk Markets

Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗

August 26, 2024

Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing...

Via Benzinga

Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients ↗

August 26, 2024

DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a prescription. Designed for people with Type 2 diabetes and prediabetes, Stelo...

Via Benzinga

Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back? ↗

August 26, 2024

The company is upbeat on its upcoming Stelo launch. The CGM is geared to people who don't use insulin.

Via Investor's Business Daily

This Is Great News for Medtronic, but Is It Time to Buy the Stock? ↗

August 26, 2024

This MedTech leader is back on track with profitable growth.

Via The Motley Fool

Donald Trump Owns These 21 Dividend Kings. Should You? ↗

August 26, 2024

Some of Trump's Dividend Kings deserve a crown more than others.

Via The Motley Fool

Topics Government

3 Unstoppable Dividend Stocks to Buy Right Now ↗

August 25, 2024

These stocks are the A-team for income investors.

Via The Motley Fool

Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally

August 23, 2024

Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.

Via MarketBeat

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

56 57 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com